title: The use of estrogen in the treatment of Parkinson's disease.
authors.affiliation: Division of Neurology, University Department of Medicine, Queen Mary Hospital, Hong Kong.
authors.forename: K L
authors.initials: KL
authors.lastname: Tsang
authors.forename: H
authors.initials: H
authors.lastname: Jiang
authors.forename: D B
authors.initials: DB
authors.lastname: Ramsden
authors.forename: S L
authors.initials: SL
authors.lastname: Ho
mesh_terms: D000978:Antiparkinson Agents / Q000627:therapeutic use*; D003342:Corpus Striatum / Q000187:drug effects; D004298:Dopamine / Q000378:metabolism; D004967:Estrogens / Q000627:therapeutic use*; D005260:Female; D020249:Hormone Replacement Therapy; D006801:Humans; D008597:Menstrual Cycle; D008780:Methyltransferases / Q000378:metabolism; D018696:Neuroprotective Agents / Q000627:therapeutic use*; D010300:Parkinson Disease / Q000188:drug therapy* / Q000503:physiopathology; D012727:Sex Characteristics; D013378:Substantia Nigra / Q000187:drug effects
chemical_list: D000978:Antiparkinson Agents; D004967:Estrogens; D018696:Neuroprotective Agents; D008780:Methyltransferases; C019608:caffeate O-methyltransferase; D004298:Dopamine